US — President Donald Trump nominated White House aide and doctor Heidi Overton to lead the US Food and Drug Administration. The nomination places Overton at the helm of an agency responsible for regulating 80% of America's food supply.

Overton must be confirmed by the Senate to assume the role, though no date has been set for her confirmation hearing. Republican Senator Bill Cassidy chairs the Senate health committee and has expressed strong concerns about Overton due to her support for Trump's orders to overhaul the childhood vaccine schedule.

The nomination comes as the agency faces scrutiny over its handling of recent disease outbreaks. The US recorded over 17,000 confirmed cases of cyclospora this summer, a substantial increase from the 1,180 confirmed cases recorded last summer. The first cases of cyclospora began in early May, and the CDC issued its first health alert on the parasite on 14 July.

Investigations linked the cyclospora outbreaks to lettuce from Taylor Farms. In response to the links to the cyclospora parasite, Taco Bell removed lettuce from its US menu. Beyond cyclospora, outbreaks of E. coli and salmonella occurred from alfalfa sprouts, eggs, jalapenos, and frozen blueberries this summer.

White House spokesperson Kush Desai defended the choice, stating that Overton has been integral to ensuring that the Administration's policies are correct, consistent, and grounded in Gold Standard Science. Desai added, "The White House looks forward to her swift confirmation by the Senate." Overton has served as the deputy assistant to the president for domestic policy since 2025.

Overton's professional background includes serving as a former general surgery resident at Johns Hopkins University School of Medicine. She also served as chief policy officer at the conservative think tank America First Policy Institute prior to her current role at the White House.

Critics point to internal challenges within the agency. Health Secretary Robert F Kennedy Jr fired 20% of FDA employees the previous year. John Swartzberg, a professor emeritus of infectious diseases at UC Berkeley's School of Public Health, said, She's taking over an agency where the morale is low. Swartzberg added, "This is going to be very difficult for her to improve."

Sarah Sorscher, a food safety advocate with the Center for Science in the Public Interest, said, "People are definitely upset about the outbreaks this summer, and they have a reason to be." She stated, "This is already a system that was teetering on the brink, and the cuts from the past year and the disruptions from the past year are pushing it over the edge." Sorscher also noted, "If we had had better boots on the ground in that [cyclospora] outbreak, we could have potentially solved it."

A Health and Human Services department spokesperson disputed claims of inadequate staffing, saying, "The Trump Administration has mounted a robust response to each outbreak." The spokesperson further stated, "FDA has the staff needed to continue investigating outbreaks, as no FDA investigators were affected by staffing changes or reductions in force."

Why It Matters

The FDA regulates 80% of America's food supply, meaning leadership changes directly affect national food safety protocols. The agency is currently managing a surge in foodborne illnesses, with cyclospora cases rising significantly compared to the previous year. The nomination occurs against a backdrop of workforce reductions, with 20% of FDA employees fired the previous year, raising questions about the agency's capacity to investigate outbreaks and maintain public trust.

What's New

Additional reporting indicates that Heidi Overton has served as the deputy assistant to the president for domestic policy since 2025. Contextual information confirms that the White House is the official residence and office of the President of the United States.